Jacobson Center for Clinical & Translational Research

Main Menu


Additional Information


Contact Us


Study Title:   A5332:  Randomized Trial to Prevent Vascular Events in HIV - REPRIEVE.  (NCT02344290)

Study Purpose:  People infected with HIV are at risk for cardiovascular disease (CVD). This study will evaluate the use of pitavastatin to reduce the risk of CVD in adults infected with HIV who are on antiretroviral therapy (ART).

Principal Investigator: Joan Duggan, MD

Study Coordinator:  For more information email Jennifer Gilmore, RN, or call 419.383.6761



Last Updated: 3/22/18